PIERRE, S.D. — South Dakota will receive $996,862.80 as part of a multistate $400 million settlement in principle with Sandoz Inc. over allegations the generic drugmaker conspired to inflate prescription drug prices and reduce competition.
Attorney General Marty Jackley said $157,474.93 will go to the state Medicaid program, with the remainder deposited into South Dakota’s antitrust special revenue fund.
The settlement, joined by 43 attorneys general, also includes requirements for Sandoz to implement antitrust compliance reforms. Additional settlements with other drug manufacturers have brought total recoveries in the litigation to approximately $496.5 million. The case remains pending final approval as states prepare for a potential 2027 trial.
Comments